Skip to content

A prospective multi-national randomized comparison of the effectiveness and safety of MiniArc and Monarc.

A prospective multi-national randomized comparison of the effectiveness and safety of MiniArc and Monarc. - MiniMo-trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33417
Enrollment
60
Registered
2009-11-26
Start date
2009-10-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stress urinary incontinence unintended urine loss.

Interventions

Surgical correction of symptomatic stress-incontinence with mini-sling (MiniArc) or trans-obturator sling (Monarc) .

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Female symptomatic stress urinary incontinence resulting from urethral hypermobility and/or ISD (intrinsic sphincter deficiency).

Exclusion criteria

Exclusion criteria: 1. Subjects who have stage 2 or more genital prolaps, according to the ICS-classification 2. Subjects who undergo surgery for recurrence of stress incontinence 3. Subjects who undergo concomitant surgical procedures 4. Subjects who are pregnant or want to become pregnant 5. Subjects are not capable of giving informed consent

Design outcomes

Primary

MeasureTime frame
1. efficacy as surgical correction of stress urinary incontinence. 2. post-operative pain.

Secondary

MeasureTime frame
3. complications. 4. morbidity and post-operative recovery. 5. the need for repeated stress-incontinence surgery or specialized physiotherapy. 6. pelvic floor function. 7. cost-effectiveness from a societal perspective.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)